New Tablets May Reduce Acne and Reduce Skin Damage

Please note: This trial has finished recruiting and is not accepting new participants.

Research Centre: RDC Global
Location: Location TBD
Lead Researcher: Amanda Rao
Ethics Committee: Reviewed and approved by the Queensland Clinical Trials Network Human Research Ethics Committee

Background

acne treatment

Acne can have lasting emotional and psychological effects, and even cause permanent scarring. RDC is investigating a treatment designed to reduce persistent acne.

The tablets also contain vitamin A, C and E which help improve vision, boost the immune system and reduce skin damage. The treatment comes in the form of a tablet to be taken with meals.

Participants will receive additional tablets at the end of the study.

Benefits to Participation

  • Your acne may improve.
  • You will be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential.
  • Upon completion, the results of the study will be shared with you.

Who Can Participate?

  • Males and Females ages 18 to 35.
  • Persistent acne.

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial